Work

Anti-CD45 Ab Pretargeted Radioimmunotherapy Using An Alpha Emitting Radionuclide (213Bi) Delivers Selective Radiation to Human Myeloid Leukemias in a Mouse Xenograft Model and Results in High Rates of Complete Remission and Long Term Survival.

Year: 2009

Type: article

Source: Blood

DOI: 10.1182/blood.v114.22.1035.1035

Authors: Aimee L. Kenoyer, Oliver W. Press, Steven I. Park, Tom Back, Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, Shani M. Wilbur, Amanda Axtman, Nural Orgun, Yukang Lin, Ajay K. Gopal, Jaideep Shenoi, Damian J. Green, Frederick R Appelbaum, John M. Pagel

Institutions: Fred Hutch Cancer Center, University of Washington, University of Gothenburg, Pacific Northwest National Laboratory

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980299075

FWCI:

Cites:

Cited by:

Related to: 10